Arsani William News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arsani william. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arsani William Today - Breaking & Trending Today

Design Therapeutics (NASDAQ:DSGN) Research Coverage Started at Wedbush

Wedbush initiated coverage on shares of Design Therapeutics (NASDAQ:DSGN – Get Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage set an “outperform” rating on the stock. A number of other analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Design Therapeutics from a […] ....

Stella Xu , Arsani William , Morgan Stanley , Design Therapeutics Inc , Securities Exchange Commission , Life Insurance Co , Zacks Investment Research , Invesco Ltd , Sg Americas Securities , Goldman Sachs Group , Group Plc , Royal Bank , Design Therapeutics , Get Rating , Investment Research , Director Arsani William , Exchange Commission , General Group Plc , Friedreich Ataxia , Myotonic Dystrophy , Nasdaq Dsgn , Initiated Coverage ,

Design Therapeutics, Inc. (NASDAQ:DSGN) Short Interest Up 37.2% in April

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Rating) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 4,060,000 shares, a growth of 37.2% from the April 15th total of 2,960,000 shares. Currently, 13.1% of the shares of the company are short sold. Based on an average trading […] ....

Stella Xu , Arsani William , Morgan Stanley , Design Therapeutics Inc , Securities Exchange Commission , Life Insurance Co , Zacks Investment Research , Piper Sandler , Sg Americas Securities , Goldman Sachs Group , Group Plc , Royal Bank , Design Therapeutics , Get Rating , Exchange Commission , Director Arsani William , General Group Plc , Investment Research , Friedreich Ataxia , Myotonic Dystrophy , Nasdaq Dsgn ,

Design Therapeutics (NASDAQ:DSGN) Shares Gap Down to $16.93

Shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $16.93, but opened at $16.28. Design Therapeutics shares last traded at $16.09, with a volume of 481 shares traded. Separately, The Goldman Sachs Group began coverage on shares of Design Therapeutics […] ....

Thomson Reuter , Stella Xu , Arsani William , Design Therapeutics Inc , Securities Exchange Commission , Goldman Sachs Group Inc , Ghost Tree Capital , Norges Bank , Blackrock Inc , Wells Fargo Company , Goldman Sachs Group , Design Therapeutics , Get Rating , Exchange Commission , Director Arsani William , Sachs Group , Friedreich Ataxia , Myotonic Dystrophy , Nasdaq Dsgn ,